These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 47211)

  • 21. Conventional immunoglobulin therapy.
    Hitzig WH; Müntener U
    Birth Defects Orig Artic Ser; 1975; 11(1):339-42. PubMed ID: 50096
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Removal of anticomplementary activity from human immune serum globulins by treatment with purified human plasmin.
    Liu DT; Grzenczyk BS; Pai RC
    Transfusion; 1979; 19(3):261-7. PubMed ID: 156418
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The value of immunotherapy with parenteral gamma globulin].
    Beaufort F; Auner H; Barandun S
    Wien Med Wochenschr; 1983; 133 Suppl 1():34-7. PubMed ID: 6197820
    [No Abstract]   [Full Text] [Related]  

  • 24. [Experimental analysis of the complement-binding activity of gamma-globulin].
    Ternovoĭ AP; Skrigan ER
    Zh Mikrobiol Epidemiol Immunobiol; 1977 Aug; (8):95-9. PubMed ID: 72470
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Immunologic properties, aggregate content and half-life of various human i.v. gamma globulin preparations].
    Ring J; Duswald KH; Seifert J; Brendel W
    Langenbecks Arch Chir; 1976; Suppl():63-7. PubMed ID: 73997
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of an intravenous gamma-globulin with Fc activities. I. Preparation and characterization of S-sulfonated human gamma-globulin.
    Masuho Y; Tomibe K; Matsuzawa K; Ohtsu A
    Vox Sang; 1977; 32(3):175-81. PubMed ID: 67713
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of high-dose intravenous immune globulin therapy for antibody deficiency syndromes.
    Sorensen RU; Polmar SH
    Am J Med; 1984 Mar; 76(3A):83-90. PubMed ID: 6424462
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The use of intravenous gamma globulin in malignant hematologic diseases].
    Garay GE
    Medicina (B Aires); 1989; 49(6):621-7. PubMed ID: 2484842
    [No Abstract]   [Full Text] [Related]  

  • 29. Development of an intravenous gamma-globulin with Fc activities. II. Reconversion of S-sulfonated human gamma-globulin into the original gamma-globulin.
    Masuho Y; Tomibe K; Watanabe T; Fukumoto Y
    Vox Sang; 1977; 32(5):290-5. PubMed ID: 67714
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Immunoglobulin FAB-fragments: specific activity and reactogenicity. III. Comparative study of the antigenic properties of anti-encephalitic gamma-globulin and FAB-fragments isolated from it].
    Barban PS; Liubimova GN; Pantiukhina AN; Misenzhnikov AV
    Zh Mikrobiol Epidemiol Immunobiol; 1977 Jun; (6):37-41. PubMed ID: 70912
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of intravenous immunoglobulin in primary humoral immunodeficiency disease.
    Cunningham-Rundles C; Siegal FP; Smithwick EM; Lion-Boulé A; Cunningham-Rundles S; O'Malley J; Barandun S; Good RA
    Ann Intern Med; 1984 Oct; 101(4):435-9. PubMed ID: 6206756
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thirty years of supplying the missing link. History of gamma globulin therapy for immunodeficient states.
    Dwyer JM
    Am J Med; 1984 Mar; 76(3A):46-52. PubMed ID: 6201067
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunoglobulin deficiency syndromes and therapy.
    Huston DP; Kavanaugh AF; Rohane PW; Huston MM
    J Allergy Clin Immunol; 1991 Jan; 87(1 Pt 1):1-17. PubMed ID: 1704022
    [No Abstract]   [Full Text] [Related]  

  • 34. Uses and abuses of plasma therapy in the patient with recurrent infections.
    Miller ME
    J Allergy Clin Immunol; 1973 Jan; 51(7):45-56. PubMed ID: 4118411
    [No Abstract]   [Full Text] [Related]  

  • 35. [Immune substitution].
    Barandun S
    Verh Dtsch Ges Inn Med; 1978; (84):481-90. PubMed ID: 84449
    [No Abstract]   [Full Text] [Related]  

  • 36. In vivo behaviour of gamma globulin preparations.
    Morell A; Schürch B; Ryser D; Hofer F; Skvaril F; Barandun S
    Vox Sang; 1980; 38(5):272-83. PubMed ID: 6158170
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravenous immune serum globulin in immunodeficiency.
    Cunningham-Rundles C
    Vox Sang; 1985; 49 Suppl 1():8-14. PubMed ID: 2416128
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Characteristics of the immunological activity of the various fractions of placental serum and gamma-globulin].
    Kiseleva IA; Mukhina NA
    Probl Gematol Pereliv Krovi; 1972 Nov; 17(11):28-31. PubMed ID: 4127607
    [No Abstract]   [Full Text] [Related]  

  • 39. [Human plasma gamma globulin injectable by intravenous route].
    Steinbuch M; Blatrix C; Dormont J; Soulier JP
    Presse Med (1893); 1969 Apr; 77(17):635-7. PubMed ID: 4182082
    [No Abstract]   [Full Text] [Related]  

  • 40. IgG subclasses in human gamma-globulin preparations for intravenous use and their reactivity with staphylococcus protein A.
    Skvaril F; Roth-Wicky B; Barandun S
    Vox Sang; 1980; 38(3):147-55. PubMed ID: 6155736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.